100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothRopinirole 0.5mg
You Searched
Ropikem 0.5mg Tablet
Chemo Healthcare Pvt. Ltd.
₹69
Our Recommendation
Ropinprime 0.5mg Tablet 10s
1,802+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Parkinson's disease / Restless leg syndrome
Customers also bought
More About Ropikem
Benefits
In Parkinson's disease Ropikem 0.5mg Tablet helps relieve symptoms of Parkinson's disease such as tremors, muscle stiffness, and difficulty moving. It increases the amount of a chemical called dopamine in the brain which helps in the coordination of body movements. This medicine can therefore enhance the quality of life by improving the ability to carry out daily functions in a better manner. In Restless leg syndrome Restless leg syndrome is a condition that causes an uncontrollable urge to move your legs, usually because of an uncomfortable sensation. It typically happens in the evening or nighttime hours when you're sitting or lying down. Moving or walking, that is change in posture, will control the unpleasant feeling temporarily. Ropikem 0.5mg Tablet helps to relieve this uncomfortable urge and calms these sensations. Take it as advised by the doctor to get the maximum relief.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Ropikem 0.5mg Tablet is to be taken with food.
How it works
Ropikem 0.5mg Tablet works by increasing the action of dopamine, a chemical messenger that is needed to control movement in the brain.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Ropikem 0.5mg Tablet .
Seek medical advice from your doctor: Ropikem 0.5mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Ropikem 0.5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. Ropikem 0.5mg Tablet suppresses serum prolactin and may interfere with breastfeeding.
Not Safe: Ropikem 0.5mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Ropikem 0.5mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Ropikem 0.5mg Tablet may be needed. Doctor consultation is advised.
Caution Advised: Ropikem 0.5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Ropikem 0.5mg Tablet may be needed. Doctor consultation is advised. Use of Ropikem 0.5mg Tablet is not recommended in patients with the severe liver disease.
What if I forget to take it?
If a dose of Ropikem 0.5mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
plot no : 1, new ahmedabad indl. estate, vill. morraiya, tal, sanand rd, changodar, gujarat 382213
References
Aminoff MJ. Pharmacologic Management of Parkinsonism & Other Movement Disorders. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 475
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1234-35
Ropinirole. Research Triangle Park, North Carolina: GlaxoSmithKline; 1997 (23 Jan. 2019)
Ropinirole. Burgos, Spain: Glaxo Wellcome S.A; 2017 (22 Mar. 2019)
Drugs and Lactation Database (LactMed) (20 Feb. 2020)
Central Drugs Standard Control Organisation (CDSCO) (22 Mar. 2019)
Ropinirole (20 Feb. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
